Please login to the form below

Not currently logged in
Email:
Password:

GSK appoints president of global pharmaceuticals

Luke Miels joins from AstraZeneca

GlaxoSmithKline Luke MielsGlaxoSmithKline has appointed Luke Miels as president of global pharmaceuticals, succeeding Abbas Hussain.

Miels joins the UK-headquartered firm from AstraZeneca, where he is currently executive vice president of AZ's European business. Prior to this, Miels served as executive vice president of global product and portfolio strategy, global medical affairs and corporate affairs.

He moved to AZ from Roche in 2014, having been regional vice president of its Asia-Pacific pharmaceutical operations, based in Shanghai, Singapore, after promotion from vice president and head of metabolism and anemia global marketing for Roche Switzerland.

He also brings management experience from Sanofi's operations in the US, Thailand, New Zealand and Australia to the role.

Emma Walmsley, GSK's chief executive officer designate, said: “Luke brings a combination of excellent R&D insight and a strong track record of commercial execution.

“We are now entering a critical period of commercialisation for our new pharmaceutical products and, over the next two to three years, we have important data to come on our early-stage pipeline.

“Luke will bring a strong new voice to the decisions and choices we will have to make for our pharmaceuticals business. I am delighted he has agreed to join GSK and look forward to welcoming him to the executive team.”

26th January 2017

From: Sales

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
COUCH.

WE ARE COUCH – a full service medical communications agency. We are a trusted partner; always striving to help make...

Latest intelligence

50 questions for delivering an exceptional healthcare brand experience
Our 50-question brand planning checklist for healthcare ensures you deliver an exceptional experience, based on what your stakeholders want and need...
The brand strategy revolution
Introducing a new tool for developing a stakeholder-centric brand, based on the experience your patients and their HCPs want and need....
How Medisafe is using AI to improve patient adherence
Dina Patel speaks to Omri Shor, Co-Founder and CEO of Medisafe, to find out how his medication management app is tackling the problem of poor adherence....

Infographics